Metabolism, distribution and elimination of lisdexamfetamine dimesylate: open-label, single-centre, phase I study in healthy adult volunteers.
about
Amphetamine, past and present--a pharmacological and clinical perspectiveOverdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and ManagementLisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of EfficacyUpdate on the management of attention-deficit/hyperactivity disorder in children and adults: patient considerations and the role of lisdexamfetamine.Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorder.Agonist replacement therapy for cocaine dependence: a translational review.Lisdexamfetamine Dimesylate Effects on the Pharmacokinetics of Cytochrome P450 Substrates in Healthy Adults in an Open-Label, Randomized, Crossover StudyMethod validation and determination of lisdexamfetamine and amphetamine in oral fluid, plasma and urine by LC-MS/MS.Pharmacokinetics of coadministered guanfacine extended release and lisdexamfetamine dimesylate.A Single-Dose, Open-Label Study of the Pharmacokinetics, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Individuals With Normal and Impaired Renal Function.Relative Bioavailabilities of Lisdexamfetamine Dimesylate and D-Amphetamine in Healthy Adults in an Open-Label, Randomized, Crossover Study After Mixing Lisdexamfetamine Dimesylate With Food or DrinkLisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD.A review of psychostimulant-induced neuroadaptation in developing animals.The use of lisdexamfetamine dimesylate for the treatment of ADHD.Metabolic, toxicological, and safety considerations for drugs used to treat ADHD.The use of lisdexamfetamine dimesylate for the treatment of ADHD and other psychiatric disorders.Lisdexamfetamine for binge eating disorder in adults: a systematic review of the efficacy and safety profile for this newly approved indication - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?Lisdexamfetamine: A Review in ADHD in Adults.Double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in college students with ADHD.Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects.Dexmedetomidine to control signs associated with lisdexamfetamine dimesylate toxidrome in a cat.Intranasal versus oral administration of lisdexamfetamine dimesylate: a randomized, open-label, two-period, crossover, single-dose, single-centre pharmacokinetic study in healthy adult men.Lisdexamfetamine dimesylate: linear dose-proportionality, low intersubject and intrasubject variability, and safety in an open-label single-dose pharmacokinetic study in healthy adult volunteers.Isotope-dilution mass spectrometric quantification of the prodrug lisdexamfetamine in human urine in doping control analysis.Lisdexamfetamine: chemistry, pharmacodynamics, pharmacokinetics, and clinical efficacy, safety, and tolerability in the treatment of binge eating disorder.Lisdexamfetamine: A Review in Binge Eating Disorder.Lisdexamfetamine Dimesylate: A Prodrug Stimulant for the Treatment of ADHD in Children and Adults
P2860
Q22241826-CC9CC19D-AC61-49E8-AF22-585BD7D00EB2Q22252568-821F29B0-6308-490E-BD09-D9C485ECFA23Q26750486-3E995EE9-F3EA-4AC1-8261-7F2C69684DC7Q33571016-7FD78054-0763-4D25-81FA-DD5FD5CE100FQ34032634-470474B7-8AB3-4BA6-87C3-B03CB7CB0DADQ35799846-4859AF3E-6A71-49D5-A270-D66070177F0BQ35807351-C6D034B4-77F5-4F28-AA8F-1438E03D82F2Q36102896-014481A2-8433-4D63-BF9C-56F9B487F565Q36947618-59990B39-DF94-4886-9584-C9A42D88594FQ37104132-A1F9A8FF-0E89-43B1-9FA5-492C1CCDD340Q37506129-DBBFC0DF-FF75-42A2-BF04-97F21C089946Q37803420-57960157-4C0D-4E9C-B108-A29E21AB8EBBQ37879918-04C66E5B-8199-46B5-8A77-25C9FA39B0F3Q37975550-18789454-C652-4438-BCE6-62897EAF6203Q37993127-E0DF931E-328A-4436-BEA8-E17077B2EE09Q38221823-BD5F2D0E-1EA6-42CA-9F41-5BE84BC9DDBBQ38370764-AAA2AF65-F6B2-4016-B4AF-65051FC352ECQ38799006-33206F18-55A2-4C16-A2F3-1D67D538CAC3Q39254667-C11076A8-8A42-4EB7-B7F9-2D49703AD714Q41312831-1136CCCE-7251-4A94-8DD3-BDCFFC22259FQ42322385-6626B5CB-1152-4E6E-B9CF-3B6FCBDFD8C3Q42599423-CC75BC52-A923-4655-8B70-C689B6C29AFDQ43155088-A1701D01-BE58-4ED0-B02C-CDD7BFF331F8Q45012725-2F3DE835-B563-479E-81D6-C1D8C5253C46Q47652489-EBE1A239-A559-4712-B5FA-191F36CDF2EBQ47663515-FA86B5D8-CB50-4589-A3CD-D3B139C340D2Q57487906-D16F1E2A-CEB0-4F9D-A0D4-D4BBCCC9D081
P2860
Metabolism, distribution and elimination of lisdexamfetamine dimesylate: open-label, single-centre, phase I study in healthy adult volunteers.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Metabolism, distribution and e ...... y in healthy adult volunteers.
@en
Metabolism, distribution and e ...... y in healthy adult volunteers.
@nl
type
label
Metabolism, distribution and e ...... y in healthy adult volunteers.
@en
Metabolism, distribution and e ...... y in healthy adult volunteers.
@nl
prefLabel
Metabolism, distribution and e ...... y in healthy adult volunteers.
@en
Metabolism, distribution and e ...... y in healthy adult volunteers.
@nl
P2093
P2860
P1476
Metabolism, distribution and e ...... y in healthy adult volunteers.
@en
P2093
Jeffrey G Stark
Michael Pennick
Suma M Krishnan
P2860
P304
P356
10.2165/0044011-200828120-00002
P577
2008-01-01T00:00:00Z